VAERS reports by lot

GSK Flu lot LN2GZ: VAERS reports

27 VAERS reports list lot LN2GZ as a GSK Flu vaccine, received between 2017-09-29 and 2018-05-18. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
27
Reports
7%
Marked serious
0
With a death outcome
5
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction3226%
Cardiac / Cardiovascular1512%
General / Systemic (non-local)1411%
Neurological1310%
Musculoskeletal119%
Respiratory108%
Gastrointestinal108%
Allergic / Anaphylactic97%
Dermatological (non-injection-site)76%
Autoimmune / Immune-mediated22%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Georgia6
Arizona2
North Carolina2
California2
South Carolina2
Illinois2
Oklahoma1
Texas1
Washington1
Virginia1
Tennessee1
Louisiana1

Reports by month received

2017-092
2017-1017
2017-114
2017-122
2018-052

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.